374 related articles for article (PubMed ID: 14595343)
1. Benefits of biotech clusters questioned.
Sheridan C
Nat Biotechnol; 2003 Nov; 21(11):1258-9. PubMed ID: 14595343
[No Abstract] [Full Text] [Related]
2. Biotech parks proliferate, despite concerns over sustainability.
Jia H; Jayaraman KS; Orellana C
Nat Biotechnol; 2003 Nov; 21(11):1259-60. PubMed ID: 14595344
[No Abstract] [Full Text] [Related]
3. More than the sum of their parts? Clustering is becoming more prevalent in the biosciences, despite concerns over the sustainability and economic effectiveness of science parks and hubs.
Rinaldi A
EMBO Rep; 2006 Feb; 7(2):133-6. PubMed ID: 16452923
[TBL] [Abstract][Full Text] [Related]
4. France to focus on a few biotech clusters.
Balcon E
Nat Biotechnol; 2004 Sep; 22(9):1063-4. PubMed ID: 15340457
[No Abstract] [Full Text] [Related]
5. Michigan's next wave of biopharmaceutical entrepreneurship.
Kerppola R; van de Walle M; Surine S
Nat Biotechnol; 2003 Sep; 21(9):1109-11. PubMed ID: 12949575
[No Abstract] [Full Text] [Related]
6. Germany biotech gets second chance.
Sheridan C
Nat Biotechnol; 2003 Dec; 21(12):1414-5. PubMed ID: 14647310
[No Abstract] [Full Text] [Related]
7. India aims to become the main bioinformatics hub.
Jayaraman KS; Louët S
Nat Biotechnol; 2004 Aug; 22(8):933. PubMed ID: 15286632
[No Abstract] [Full Text] [Related]
8. Realizing potential: the state of Asian bioentrepreneurship.
Tang CM; Mahmud MA; Foo FK; Chu SY; Chiu RI; Tanticharoen M; Zhang L; Chang TW
Nat Biotechnol; 2003 Jul; 21 Suppl():BE15-22. PubMed ID: 12874972
[No Abstract] [Full Text] [Related]
9. Little science, big bucks.
DeFrancesco L
Nat Biotechnol; 2003 Oct; 21(10):1127-9. PubMed ID: 14520387
[No Abstract] [Full Text] [Related]
10. Increasing number of companies found ineligible for SBIR funding.
Bouchie A
Nat Biotechnol; 2003 Oct; 21(10):1121-2. PubMed ID: 14520384
[No Abstract] [Full Text] [Related]
11. New biotech oasis?
Sheridan C
Nat Biotechnol; 2005 Aug; 23(8):919. PubMed ID: 16114121
[No Abstract] [Full Text] [Related]
12. Chasing biotech, state by state--winners and losers.
Wilan KH
Nat Biotechnol; 2005 Feb; 23(2):175-9. PubMed ID: 15696143
[No Abstract] [Full Text] [Related]
13. Taiwan: Biotech vision.
Cyranoski D
Nat Biotechnol; 2003 Apr; 21(4):463-4. PubMed ID: 12665831
[No Abstract] [Full Text] [Related]
14. China moves to reform biotech policies.
Jia H
Nat Biotechnol; 2004 Oct; 22(10):1197. PubMed ID: 15470442
[No Abstract] [Full Text] [Related]
15. The YIC factor.
Nat Biotechnol; 2005 Oct; 23(10):1187. PubMed ID: 16211041
[No Abstract] [Full Text] [Related]
16. Germany reattempts to spark innovation.
Habeck M
Nat Biotechnol; 2004 Mar; 22(3):257-8. PubMed ID: 14990939
[No Abstract] [Full Text] [Related]
17. First U.S.-Russian business venture in closed nuclear city.
Lopatto J; Wilkes B
Health Phys; 2004 Feb; 86(2):212-3. PubMed ID: 14744060
[No Abstract] [Full Text] [Related]
18. Boutiques reborn in 2003.
Surendran A
Nat Biotechnol; 2004 Mar; 22(3):353-4. PubMed ID: 15017987
[No Abstract] [Full Text] [Related]
19. Superscience me!
Nat Biotechnol; 2007 Jun; 25(6):604. PubMed ID: 17557082
[No Abstract] [Full Text] [Related]
20. Earlier stage biotechs attract partners.
Ratner M
Nat Biotechnol; 2005 May; 23(5):509. PubMed ID: 15877052
[No Abstract] [Full Text] [Related]
[Next] [New Search]
